News Detail

Celularity names Rick Gonzalez chief commercial officer

PUBT · 06/03 12:06

Listen to the news

Celularity names Rick Gonzalez chief commercial officer

Celularity named Rick Gonzalez chief commercial officer, effective May 29, 2026.
He will run global commercial strategy for cenplacel-L, Lifebank, and the broader regenerative medicine portfolio, reporting to CEO Robert J. Hariri.
Gonzalez previously served as chief commercial officer at Alume Biosciences, leading commercialization strategy for a clinical-stage surgical visualization platform.
He was also CEO of Navidea Biopharmaceuticals, driving 2.5x year-over-year revenue growth, and held senior roles at Spectrum Pharmaceuticals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606030800PRIMZONEFULLFEED9731118) on June 03, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.